DEFINITIVE CONTRACT
Active75F40126C00095
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$995.4K
obligated · signed 2 months ago
BAA FY2600123 DEVELOPING STANDARDIZED CASE DEFINITION FOR ADVERSE EVENTS
Performance timeline
Start
Sep 1, 2026
End
Aug 31, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Aug 31, 2027
THE TASK FORCE FOR GLOBAL HEALTH, INC.
Contract 75F40126C00095
UEI
L9DLXYHZ3TM8
Parent Company
TASK FORCE FOR GLOBAL HEALTH, INC
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$995,374
Base + Exercised Options
$995,374
Total Ceiling Value
$995,374
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.